Equities

Co-Diagnostics Inc

Co-Diagnostics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.29
  • Today's Change0.02 / 1.57%
  • Shares traded73.62k
  • 1 Year change+25.24%
  • Beta-0.8620
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

  • Revenue in USD (TTM)9.14m
  • Net income in USD-37.57m
  • Incorporated2013
  • Employees155.00
  • Location
    Co-Diagnostics Inc4049 S Highland DrSALT LAKE CITY 84124-1664United StatesUSA
  • Phone+1 (801) 278-9769
  • Websitehttp://codiagnostics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Icecure Medical Ltd3.34m-13.69m32.19m71.00--3.03--9.65-0.2934-0.29340.07140.21430.17530.843615.0646,985.91-71.93-54.89-92.10-68.6640.3249.87-410.22-313.192.54--0.00--4.6723.5013.70--48.10--
SANUWAVE Health Inc24.90m-3.43m33.08m31.00------1.33-0.0095-0.00950.0218-0.03351.243.908.34803,064.50-17.07-136.54----71.5769.13-13.79-189.600.09990.1199----21.8461.61-150.72------
Vicarious Surgical Inc0.00-61.02m34.56m131.00--0.4795-----10.77-10.770.0012.220.00----0.00-61.68---66.62--------------0.00-------1,478.15------
United Health Products Inc0.00-1.84m34.73m6.00---------0.0075-0.00750.00-0.00810.000.00--0.00-662.95-6,446.86------53.19---132,561.200.0126-15.12-----100.00---55.45------
Accelerate Diagnostics Inc12.23m-37.91m34.81m134.00------2.85-2.07-2.070.6853-1.470.33632.145.2891,291.05-104.22-75.24-1,349.93-94.4627.1635.08-309.87-638.551.04--6.38---5.4316.291.40--0.7307--
Vaso Corp80.33m2.26m35.08m300.0012.961.3111.190.43670.01540.01540.45710.15241.1022.599.62267,766.703.107.605.0416.6261.2058.392.815.821.48--0.0028--2.181.84-57.46---22.33--
Movano Inc852.00k-26.83m35.62m30.00--2.12--41.81-0.4527-0.45270.01310.16960.0444--3.3828,400.00-139.74-151.50-176.37-188.58-87.21---3,149.06--5.23--0.0025------3.45--4.24--
BioNano Genomics Inc36.58m-204.10m36.12m344.00--0.37--0.9874-5.15-5.150.74961.140.18261.005.28106,334.30-101.86-56.82-123.67-67.8328.9725.38-557.98-505.761.11-61.510.0455--29.9024.65-75.34--38.51--
Precision Optics Corporation Inc19.41m-1.64m37.15m84.00--3.15--1.91-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
Rapid Micro Biosystems Inc24.71m-50.46m37.29m193.00--0.3942--1.51-1.17-1.170.57112.200.17781.335.58128,036.30-36.30---40.86---14.22---204.22--4.62--0.003--31.44--13.71------
Apyx Medical Corp49.03m-28.37m37.76m252.00--2.56--0.7702-0.8188-0.81881.420.42570.76721.823.96194,567.50-44.55-25.24-58.21-29.9761.9066.11-58.08-46.004.45-7.790.693--17.6125.8219.28--7.99--
T2 Biosystems Inc7.16m-48.26m38.46m113.00------5.37-10.70-10.701.09-0.33910.24352.825.4163,398.23-164.01-106.01---253.03-86.96-12.60-673.67-317.930.359-12.442.00---67.75-7.2919.66---20.19--
electroCore, Inc.21.28m-14.23m38.69m68.00--3.37--1.82-2.19-2.193.251.781.161.4154.85312,955.90-77.78-70.73-125.05-88.9683.6175.81-66.84-352.822.12--0.00--86.5774.4215.02---5.88--
Co-Diagnostics Inc9.14m-37.57m40.53m155.00--0.5598--4.44-1.27-1.270.30772.270.09441.1911.0858,948.20-38.835.77-41.046.1559.8382.24-411.1910.948.81--0.000.00-80.09179.54-148.15--101.27--
iCAD Inc18.80m-4.54m41.40m67.00--1.33--2.20-0.1735-0.0880.71851.170.44881.063.14280,537.30-10.84-23.94-13.90-34.1486.0476.96-24.16-45.024.13--0.00---12.54-7.5329.32--23.88--
Lucid Diagnostics Inc3.80m-54.15m44.20m70.00------11.63-1.23-1.230.08570.32380.0992--38.9754,285.71-121.82---274.96---67.39---1,227.76--1.71--0.4178--544.03--6.24------
Data as of Sep 20 2024. Currency figures normalised to Co-Diagnostics Inc's reporting currency: US Dollar USD

Institutional shareholders

13.19%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20241.77m5.54%
Renaissance Technologies LLCas of 30 Jun 2024587.00k1.84%
BlackRock Fund Advisorsas of 30 Jun 2024495.33k1.55%
Geode Capital Management LLCas of 30 Jun 2024317.38k1.00%
Bridgeway Capital Management LLCas of 30 Jun 2024272.90k0.86%
Susquehanna Financial Group LLLPas of 30 Jun 2024201.57k0.63%
Degroof Petercam Asset Services SAas of 31 Dec 2022182.00k0.57%
Kestra Advisory Services LLCas of 30 Jun 2024149.87k0.47%
Newton Investment Management North America LLCas of 30 Jun 2024133.96k0.42%
SSgA Funds Management, Inc.as of 30 Jun 2024100.65k0.32%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.